Repaglinide brand names: Guide to its use and function
"Repaglinide is an insulin secretagogue that lowers blood glucose levels in patients with T2DM."
Repaglinide brand names vary by region, though one primary commercial identity emerged through specific regulatory filings. This guide examines the historical development and market presence of the medication, focusing on its transition from a licensed compound to an FDA-approved treatment.
You will learn about the brand's regulatory timeline, its mechanism of action, and the specific absorption characteristics that define its use.
What are the main brand names for repaglinide?
In the quiet office at sunset, she ran her fingers over the dusty labels to identify each brand name for repaglinide. A researcher looks through a stack of pharmaceutical documents to identify different market labels. In the United States, the drug is widely recognized as Prandin. This specific name was established following a successful application process in the late 1990s.
According to Wikipedia, the drug that became repaglinide was later licensed by Boehringer to Novo Nordisk. This transition allowed for the development of the commercial product seen in many markets today.
Following this licensing, the company moved forward with the formal regulatory steps required for market entry.
Novo Nordisk filed its New Drug Application (NDA) for Prandin in July 1997. This filing was a critical step in bringing the medication to the American market. The brand name Prandin was quickly approved, gaining FDA approval in December 1997.
How does the drug function in the body? Repaglinide brand names
A clinician examines a blood glucose monitor while discussing insulin secretion with a patient. Repaglinide acts as a tool to manage blood sugar through a specific physiological mechanism.
According to the American journal of cardiovascular drugs, repaglinide is an insulin secretagogue that lowers blood glucose levels in patients with T2DM.
Repaglinide is an insulin secretagogue that lowers blood glucose levels in patients with T2DM. By stimulating the release of insulin, it helps manage the glycemic levels of those living with type 2 diabetes. This mechanism is central to its therapeutic use in daily life.
The biological impact of the drug depends on how it interacts with the body's natural processes. It is designed to target specific cells to assist in glucose regulation. Understanding these diabetes drug brand names helps patients recognize the purpose of their medication.
How does the medication get absorbed? A patient prepares a meal while checking the timing of their medication. The way the body processes the drug is heavily influenced by the timing of ingestion and the presence of food.
According to the Journal of clinical pharmacology, compared to administration of repaglinide alone, concomitant ketoconazole increased mean AUC0-infinity for repaglinide by 15% and mean Cmax by 7%.
The drug has a 56% bioavailability when absorbed from the gastrointestinal tract. This percentage represents the portion of the dose that reaches systemic circulation to perform its intended function. Absorption is a key factor in how the medication is managed.
Bioavailability is reduced when taken with food; the maximum concentration decreases by 20%. This reduction means that the amount of drug in the blood can change based on dietary intake. Because of this, timing is essential for maintaining consistent levels.
How should patients manage their dosing?
A person sits at a kitchen table, checking their watch before a scheduled meal. Proper timing ensures the medication works effectively when the body needs insulin the most.
The tablets are taken before meals, any time from 30 minutes before a meal to just before the meal. This timing aligns the drug's peak effect with the glucose spikes that occur after eating. Taking the medication at the right moment is a fundamental part of the regimen.
Managing the dosage requires consistency to avoid fluctuations in blood sugar. Patients must coordinate their intake with their eating habits to mitigate the impact of food on absorption. This routine helps maintain the stability of the treatment.
- Take the medication before meals.
- Adjust the dose based on carbohydrate intake.
- Monitor blood glucose levels regularly.
What are the distribution and excretion details?
A scientist reviews laboratory data regarding protein binding and metabolic clearance. The movement of the drug through the bloodstream and its eventual removal are governed by specific biological properties.
The protein binding of repaglinide to albumin is greater than 98%. This high level of binding means most of the drug is attached to proteins in the blood. This characteristic affects how much of the drug is available to act on tissues.
Regarding how the body clears the substance, repaglinide is 90% excreted in the feces and 8% in the urine. This distribution shows how the body handles the elimination of the compound. These pathways ensure the drug does not remain indefinitely in the system.
In this sequence, the second step is the most critical.
Summary of medication characteristics
A pharmacist organizes various medication types on a shelf, noting the differences in their profiles. Comparing the identity and the biological behavior of the drug provides a clearer picture of its clinical use.
| Characteristic | Detail |
|---|---|
| Primary Brand Name | Prandin |
| Protein Binding | > 98% |
I observed that the timing of the dose is as important as the drug itself when considering the 20% decrease in maximum concentration caused by food.
The primary limitation of this topic is that while brand names like Prandin are specific to certain regions, the drug's biological properties like 56% bioavailability remain constant across different markets.
The subject here is Repaglinide brand names.
The same subject is also called Gluformin global brands.
The same subject is also called Repaglinide market share.
The same subject is also called Diabetic medication brands.
This part also covers Repaglinide country availability.
This part also covers Global diabetes drug sales.
This part also covers Brand comparison Repaglinide.
Repaglinide country availability
Related
When should the patient take the medication?
The tablets should be taken before meals, allowing a window of time from thirty minutes preceding the meal up to immediately before the meal begins. This timing ensures that the drug's peak effect coincides with the post-meal rise in blood glucose levels.
Coordinating the intake of repaglinide with the eating schedule is a fundamental part of the prescribed treatment regimen.
What influences the drug's movement through the body?
The movement of repaglinide through the bloodstream and its eventual clearance is dictated by its inherent biological properties. The drug achieves greater than ninety-eight percent protein binding to albumin, meaning most of the compound remains attached to blood proteins.
This binding status influences the amount of the drug available to interact with target tissues.
Disclaimer: This article is general information, not medical advice. Consult a qualified healthcare professional before taking any supplement or medication.
Comments 0